Through these and other pathways (NF-κB, STAT3, PI3K/Akt, etc.), EV-delivered miRNAs orchestrate multiple aspects of lung cancer progression, including proliferation, invasion, immune suppression, and metastatic niche formation. This evidence concerns the gene NFKB1 and lung carcinoma.